Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Inhibitors of NF-κB signaling: 785 and counting
TD Gilmore, M Herscovitch - Oncogene, 2006 - nature.com
Nuclear factor kappa B (NF-κB) transcription factors regulate several important physiological
processes, including inflammation and immune responses, cell growth, apoptosis, and the …
processes, including inflammation and immune responses, cell growth, apoptosis, and the …
Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment
Hodgkin's lymphoma (HL) represents the most common subtype of malignant lymphoma in
young people in the Western world. Most patients can be cured with modern treatment …
young people in the Western world. Most patients can be cured with modern treatment …
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
C Nakanishi, M Toi - Nature Reviews Cancer, 2005 - nature.com
The cytotoxicity of chemotherapeutic agents is attributed to apoptosis. Acquired resistance to
the effects of chemotherapy has emerged as a significant impediment to effective cancer …
the effects of chemotherapy has emerged as a significant impediment to effective cancer …
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells
ST Nawrocki, JS Carew, K Dunner Jr, LH Boise… - Cancer …, 2005 - aacrjournals.org
Bortezomib (Velcade, formerly known as PS-341) is a boronic acid dipeptide derivative that
is a selective and potent inhibitor of the proteasome. We hypothesized that proteasome …
is a selective and potent inhibitor of the proteasome. We hypothesized that proteasome …
Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells
ST Nawrocki, JS Carew, MS Pino, RA Highshaw… - Cancer …, 2006 - aacrjournals.org
The proteasome inhibitor bortezomib (formerly known as PS-341) recently received Food
and Drug Administration approval for the treatment of multiple myeloma, and its activity is …
and Drug Administration approval for the treatment of multiple myeloma, and its activity is …
Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma
P Bonvini, E Zorzi, G Basso, A Rosolen - Leukemia, 2007 - nature.com
The 26S proteasome has a direct impact on cellular transcription regulation, cell-cycle
progression, oncogenesis and apoptosis, since the turnover of the vast majority of …
progression, oncogenesis and apoptosis, since the turnover of the vast majority of …
Characterization of curcuemulsomes: Nanoformulation for enhanced solubility anddelivery of curcumin
MH Ucisik, S Küpcü, B Schuster, UB Sleytr - Journal of nanobiotechnology, 2013 - Springer
Background Curcumin is a polyphenolic compound isolated from the rhizomes of the
plantCurcuma longa and shows intrinsic anti-cancer properties. Its medical useremains …
plantCurcuma longa and shows intrinsic anti-cancer properties. Its medical useremains …
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications
Y Fernández, M Verhaegen, TP Miller, JL Rush… - Cancer …, 2005 - aacrjournals.org
Melanoma is the most aggressive form of skin cancer and advanced stages are invariably
resistant to conventional therapeutic agents. Using bortezomib as a prototypic proteasome …
resistant to conventional therapeutic agents. Using bortezomib as a prototypic proteasome …
[HTML][HTML] NFkB pathway and Hodgkin lymphoma
F Jardin - Biomedicines, 2022 - mdpi.com
The tumor cells that drive classical Hodgkin lymphoma (cHL), namely, Hodgkin and Reed-
Sternberg (HRS) cells, display hallmark features that include their rareness in contrast with …
Sternberg (HRS) cells, display hallmark features that include their rareness in contrast with …
Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
D Aldinucci, M Celegato, N Casagrande - Cancer letters, 2016 - Elsevier
Classical Hodgkin lymphoma (cHL) is characterized by few tumor cells surrounded by
immune cells, fibroblasts, specialized mesenchymal stromal cells and endothelial cells …
immune cells, fibroblasts, specialized mesenchymal stromal cells and endothelial cells …